TWI597279B - 2-甲醯胺環胺基脲衍生物之合成 - Google Patents

2-甲醯胺環胺基脲衍生物之合成 Download PDF

Info

Publication number
TWI597279B
TWI597279B TW101107070A TW101107070A TWI597279B TW I597279 B TWI597279 B TW I597279B TW 101107070 A TW101107070 A TW 101107070A TW 101107070 A TW101107070 A TW 101107070A TW I597279 B TWI597279 B TW I597279B
Authority
TW
Taiwan
Prior art keywords
compound
formula
solvent
group
tetrahydrofuran
Prior art date
Application number
TW101107070A
Other languages
English (en)
Chinese (zh)
Other versions
TW201247660A (en
Inventor
柏哈德 艾柏
伊莎貝爾 席爾維 加勞
佛羅里安 卡爾 科林貝克
Original Assignee
諾華公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI597279(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 諾華公司 filed Critical 諾華公司
Publication of TW201247660A publication Critical patent/TW201247660A/zh
Application granted granted Critical
Publication of TWI597279B publication Critical patent/TWI597279B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW101107070A 2011-03-03 2012-03-02 2-甲醯胺環胺基脲衍生物之合成 TWI597279B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (2)

Publication Number Publication Date
TW201247660A TW201247660A (en) 2012-12-01
TWI597279B true TWI597279B (zh) 2017-09-01

Family

ID=45787206

Family Applications (2)

Application Number Title Priority Date Filing Date
TW101107070A TWI597279B (zh) 2011-03-03 2012-03-02 2-甲醯胺環胺基脲衍生物之合成
TW106106845A TWI607994B (zh) 2011-03-03 2012-03-02 2-甲醯胺環胺基脲衍生物之合成

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW106106845A TWI607994B (zh) 2011-03-03 2012-03-02 2-甲醯胺環胺基脲衍生物之合成

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN106083840B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA025381B1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI597279B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
MXPA02002559A (es) 1999-09-10 2002-07-30 Merck & Co Inc Inhibidores de tirosina cinasa.
AR044519A1 (es) * 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
JP2009524677A (ja) * 2006-01-25 2009-07-02 シンタ ファーマシューティカルズ コーポレーション 炎症および免疫関連使用用のチアゾールおよびチアジアゾール化合物
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
JP2011506560A (ja) * 2007-12-20 2011-03-03 ノバルティス アーゲー Pi3キナーゼ阻害剤として用いられるチアゾール誘導体
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
US9776966B2 (en) 2017-10-03
US9650373B2 (en) 2017-05-16
KR101851421B1 (ko) 2018-04-23
US20170240509A1 (en) 2017-08-24
KR20140009432A (ko) 2014-01-22
PT2681192T (pt) 2018-04-02
EP2681192A1 (en) 2014-01-08
EA025381B1 (ru) 2016-12-30
PL2681192T3 (pl) 2018-06-29
SG192793A1 (en) 2013-09-30
CL2013002521A1 (es) 2014-02-14
CN103402982B (zh) 2016-07-13
AU2012222346A1 (en) 2013-08-29
CA2828509C (en) 2018-11-20
IL228023A (en) 2017-04-30
ES2663717T3 (es) 2018-04-16
ZA201306174B (en) 2014-05-28
CN106083840B (zh) 2020-01-03
CN106083840A (zh) 2016-11-09
TW201247660A (en) 2012-12-01
EP2681192B1 (en) 2017-12-27
MA34982B1 (fr) 2014-03-01
MX351740B (es) 2017-10-26
EA201892052A1 (ru) 2019-02-28
US10059670B2 (en) 2018-08-28
JP2014511387A (ja) 2014-05-15
SI2681192T1 (en) 2018-04-30
NZ614173A (en) 2015-04-24
GT201300211A (es) 2014-12-30
US20170355677A1 (en) 2017-12-14
NO2681192T3 (enExample) 2018-05-26
CO6751286A2 (es) 2013-09-16
UA112539C2 (uk) 2016-09-26
MX2013010132A (es) 2013-10-30
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
JP6022485B2 (ja) 2016-11-09
TWI607994B (zh) 2017-12-11
ECSP13012914A (es) 2013-11-29
CA2828509A1 (en) 2012-09-07
DK2681192T3 (en) 2018-04-16
TN2013000354A1 (en) 2015-01-20
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
AR088714A1 (es) 2014-07-02
BR112013021882A2 (pt) 2016-07-19
EA201792068A3 (ru) 2018-05-31
PE20140917A1 (es) 2014-08-14
EA201391267A1 (ru) 2014-01-30
HUE036319T2 (hu) 2018-06-28
EA032802B1 (ru) 2019-07-31
EA201792068A2 (ru) 2018-01-31
WO2012117071A1 (en) 2012-09-07
US20130331579A1 (en) 2013-12-12
IL228023A0 (en) 2013-09-30
PH12013501796A1 (en) 2022-10-26
AU2012222346B2 (en) 2015-05-07
CN103402982A (zh) 2013-11-20
EA201691331A1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
TWI607994B (zh) 2-甲醯胺環胺基脲衍生物之合成
RS59100B1 (sr) Antitela usmerena protiv her-3 i njihove upotrebe
KR20150021070A (ko) 피롤로[2,3-b]피리딘의 합성
TW202216692A (zh) 新型Rho相關蛋白激酶抑制劑的製備方法和此製備方法中的中間體
RU2533708C2 (ru) Азотсодержащее гетероциклическое соединение и способ его получения
WO2023037237A1 (en) Process for the preparation of remimazolam
US20230278960A1 (en) Novel acridinium salt and method for producing same
AU2022420983A1 (en) Bifunctional sulphonamide compounds
MXPA02012884A (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas.
US20120142929A1 (en) Process for preparing sulfonyl quinolines
KR101674557B1 (ko) 우수한 안정성을 가지는 아조메틴 일라이드 제조방법 및 다성분 [5+2] 고리화 첨가반응을 통한 1,4-다이아제핀 유도체 제조방법
CN109153645B (zh) 制备6-炔基-吡啶衍生物的方法
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
NZ614173B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
EA049707B1 (ru) Способ получения ингибитора cyp11a1 и соответствующих промежуточных соединений
JP2023524241A (ja) ベルジペルスタットの調製のためのプロセス
JP2008543761A (ja) 3−アミノ−4−置換ピラゾール誘導体の合成

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees